|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
8894976 |
| 003 |
ICU |
| 005 |
20120829140100.0 |
| 006 |
m d |
| 007 |
cr cn| |
| 008 |
101004s2010 nyua ob 001 0 eng d |
| 019 |
|
|
|a 676821931
|
| 020 |
|
|
|a 9781441961020
|
| 020 |
|
|
|a 144196102X
|
| 020 |
|
|
|a 9781441961013 (hbk)
|
| 020 |
|
|
|a 1441961011 (hbk)
|
| 035 |
|
|
|a (OCoLC)668099002
|z (OCoLC)676821931
|
| 037 |
|
|
|a 978-1-4419-6101-3
|b Springer
|n http://www.springerlink.com
|
| 040 |
|
|
|a GW5XE
|b eng
|c GW5XE
|d VAM
|d CEF
|d OCLCQ
|d IAK
|d N$T
|d E7B
|d EBLCP
|d OCLCQ
|d YDXCP
|d OHS
|d COO
|
| 049 |
|
|
|a CGUA
|
| 072 |
|
7 |
|a MED
|x 062000
|2 bisacsh
|
| 072 |
|
7 |
|a HEA
|x 039030
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.9940695
|2 22
|
| 090 |
|
|
|a RC271.G45
|b G46 2010
|
| 096 |
|
|
|a QZ 266
|
| 245 |
0 |
0 |
|a Gene-based therapies for cancer /
|c edited by Jack A. Roth.
|
| 260 |
|
|
|a New York ;
|a London :
|b Springer,
|c 2010.
|
| 300 |
|
|
|a 1 online resource (xiv, 275 p.) :
|b ill. (some col.)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/c
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/cr
|
| 490 |
0 |
|
|a Current cancer research
|
| 505 |
0 |
|
|a RNAi: a new paradigm in cancer gene therapy -- Gene-based therapy for cancer: brain tumors -- Gene therapy of prostate cancer -- siRNA versus shRNA for personalized cancer therapy: mechanisms and applications -- Tumor suppressor gene therapy -- Targeted oncolytic adenovirus for human cancer therapy: gene-based therapies for cancer -- Gene therapy for malignant pleural mesothelioma -- Mesenchymal stem/stromal cells as cellular vehicles for tumor targeting -- Retargeting adenovirus for cancer gene therapy -- Lentiviruses: vectors for cancer gene therapy -- Interleukin-24 gene therapy for melanoma -- Herpes simplex virus 1 for cancer therapy -- Telomerase as a target for cancer therapeutics -- Gene therapy for sarcoma.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record.
|
| 650 |
|
0 |
|a Cancer
|x Gene therapy.
|0 http://id.loc.gov/authorities/subjects/sh92005201
|
| 650 |
|
2 |
|a Neoplasms
|x genetics.
|
| 650 |
|
2 |
|a Gene Therapy.
|
| 650 |
|
2 |
|a Genes, Tumor Suppressor.
|
| 650 |
|
4 |
|a Medicine.
|
| 650 |
|
7 |
|a MEDICAL
|x Oncology.
|2 bisacsh
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Cancer.
|2 bisacsh
|
| 655 |
|
4 |
|a Electronic books.
|
| 650 |
|
7 |
|a Cancer
|x Gene therapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00845367
|
| 700 |
1 |
|
|a Roth, Jack A.
|0 http://id.loc.gov/authorities/names/n86130800
|1 http://viaf.org/viaf/12636416
|
| 776 |
0 |
8 |
|i Print version:
|t Gene-based therapies for cancer.
|d New York ; London : Springer, 2010
|z 9781441961013
|z 1441961011
|w (OCoLC)502033990
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-1-4419-6102-0
|y SpringerLink
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (ICU)8894976
|
| 929 |
|
|
|a eresource
|
| 999 |
f |
f |
|i f5589102-8fe7-55aa-94aa-c5ab0d630f2b
|s 731f05f7-528b-514f-b662-f887a83e5a3a
|
| 928 |
|
|
|t Library of Congress classification
|a RC271.G45 G46 2010
|l Online
|c UC-FullText
|u http://dx.doi.org/10.1007/978-1-4419-6102-0
|z SpringerLink
|g ebooks
|i 11478517
|
